Summary & Overview
CPT 80331: Multi-Analyte Nonopioid Analgesic Detection
CPT code 80331 designates a laboratory test that detects or measures six or more nonopioid analgesic medications in a patient specimen. This multi-analyte toxicology panel is used in clinical care to identify presence and relative quantities of common nonopioid pain medications, supporting medication management, adherence assessment, and safety monitoring. Nationally, such panels influence laboratory utilization, payer coverage policies, and clinical decision workflows in settings that manage pain and medication reconciliation.
Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication reviews how these payers approach coverage and claims handling for multi-analyte nonopioid analgesic testing, and summarizes common modifiers and billing considerations associated with laboratory services of this type. If detailed payer-specific policies are not provided, the reader will find a national-level overview and notes where data are not available.
Readers will learn the clinical context for ordering CPT code 80331, typical sites of service where the test is performed, and the types of information payers evaluate when setting coverage policies for multi-analyte nonopioid analgesic testing. The report also outlines what benchmark metrics and policy updates are commonly relevant to this service and identifies gaps where Data not available in the input.
Billing Code Overview
CPT code 80331 describes a laboratory assay in which a lab analyst measures the amount of or detects the presence of six or more nonopioid analgesics in a patient specimen. This service is a multi-analyte toxicology panel focused on nonopioid pain medications.
-
Service type: Clinical laboratory testing — multi-analyte nonopioid analgesic detection
-
Typical site of service: Clinical laboratory or hospital laboratory; specimens are collected in outpatient clinics, emergency departments, or inpatient units and processed in a certified laboratory
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult presenting for toxicology testing after a pain clinic visit, emergency department encounter for uncontrolled pain, or preoperative assessment when medication compliance or ingestion of prescribed and nonprescribed analgesics must be verified. The clinician orders a qualitative or semiquantitative urine or plasma drug test to detect presence of six or more nonopioid analgesics (for example, acetaminophen, NSAIDs, salicylates, tramadol when considered nonopioid by facility policy, and other common nonopioid pain medications). A specimen is collected (usually urine) at the ambulatory clinic, hospital outpatient laboratory, pain management clinic, or emergency department. The clinical laboratory performs an immunoassay screen followed by confirmatory testing (when indicated) using mass spectrometry or other analytic methods capable of detecting multiple analytes; results are reported to the ordering provider and documented in the electronic health record. Typical sites of service include hospital outpatient laboratories, independent clinical laboratories, ambulatory surgery centers (if testing related to perioperative assessment), emergency departments, and outpatient physician offices with laboratory capability.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the professional interpretation/reporting portion of the test is billed separately from the technical component. |